Private Trust Company’s Soleno Therapeutics SLNO Stock Holding History

Private Trust Company’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$67	–	2789
2026 Q1	$67	Hold	2	–	–	﹤0.01%	2591
2025 Q4	$93	Hold	2	–	–	﹤0.01%	2527
2025 Q3	$135	Buy	+2	New	+$148	﹤0.01%	2535

Private Trust Company's SLNO Position: Q2 2026 in Review

Private Trust Company sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 2 shares — an estimated $67 sold.

Private Trust Company first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $135 in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Private Trust Company reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Private Trust Company sold 2 Soleno Therapeutics shares in Q2 2026, an estimated $67.
Private Trust Company first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
Private Trust Company's Soleno Therapeutics position peaked at $135 in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.